Epigenetic reader domain inhibitor CPI 0610, Purity ≥98%

Cat. No.: X24-05-ZQ437

Epigenetic reader domain inhibitor CPI 0610, Purity ≥98%

Synonym: 1380087-89-7; CPI0610; CPI-0610; Epigenetic reader domain inhibitor

  • CAS Number: 1380087-89-7
  • Compound CID: 57389999
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CPI 0610, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals. It targets BRD4-BD1, and MYC.
Molecular Weight
365.82
Molecular Formula
C20H16ClN3O2
Targets
BRD4-BD1: 39 nM; MYC: 180 nM (EC50)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 70 mg/mL (191.35 mM); Water: Insoluble; Ethanol: 12 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CPI 0610 can be used to study the therapeutic potential of BET inhibition in hematologic malignancies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.